claim
In the Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial (STABILITY) and the Stabilization of Plaques using Darapladib — Thrombosis in Myocardial Infarction 52 (SOLID-TIMI 52) trial, interleukin-6 (IL-6) was significantly and independently associated with incident cardiovascular events, including cardiovascular death, myocardial infarction, and heart failure.
Authors
Sources
- EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org via serper
Referenced by nodes (5)
- interleukin-6 concept
- cardiovascular events concept
- myocardial infarction concept
- heart failure concept
- stability concept